5VL-33525-68185
4 vaccinations
0 coded responses
16 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 231 / VA
- Registered
- 2021-09-27
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-09-27
Registered in v-safe
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-09-27
- 2021-09-28
- 2021-09-29
- 2021-09-30
- 2021-10-02
- 2021-10-13
- 2021-10-18
- 2021-11-01
-
2022-12-27
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-12-27
- 2022-12-28
- 2022-12-29
- 2022-12-30
- 2023-01-01
- 2023-01-03
- 2023-01-13
- 2023-02-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | No |
| 2 | 2021-01-14 | Pfizer-BioNTech | No |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-12-27 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.